Oramed Pharmaceuticals (ORMP) Free Cash Flow (QoQ) (2011 - 2026)
Oramed Pharmaceuticals (ORMP) Free Cash Flow (QoQ) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-523.93% |
| Dec 31, 2025 |
71.20% |
| Sep 30, 2025 |
54.08% |
| Jun 30, 2025 |
-0.48% |
| Mar 31, 2025 |
-83.25% |
| Dec 31, 2024 |
72.95% |
| Sep 30, 2024 |
-442.29% |
| Jun 30, 2024 |
240.46% |
| Mar 31, 2024 |
-4.01% |
| Dec 31, 2023 |
-95.73% |
| Sep 30, 2023 |
72.65% |
| Jun 30, 2023 |
53.83% |
| Mar 31, 2023 |
31.33% |
| Dec 31, 2022 |
-254.36% |
| Sep 30, 2022 |
72.24% |
| Jun 30, 2022 |
7.22% |
| Nov 30, 2021 |
40.34% |
| Aug 31, 2021 |
-105.16% |
| May 31, 2021 |
-71.85% |
| Feb 28, 2021 |
49.23% |
